116 related articles for article (PubMed ID: 37745452)
1. Finding Drug Repurposing Candidates for Neurodegenerative Diseases using Zebrafish Behavioral Profiles.
Hernández TDR; Gore SV; Kreiling JA; Creton R
bioRxiv; 2023 Sep; ():. PubMed ID: 37745452
[TBL] [Abstract][Full Text] [Related]
2. Drug repurposing for neurodegenerative diseases using Zebrafish behavioral profiles.
Del Rosario Hernández T; Gore SV; Kreiling JA; Creton R
Biomed Pharmacother; 2024 Feb; 171():116096. PubMed ID: 38185043
[TBL] [Abstract][Full Text] [Related]
3. Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles.
Tucker Edmister S; Del Rosario Hernández T; Ibrahim R; Brown CA; Gore SV; Kakodkar R; Kreiling JA; Creton R
Sci Rep; 2022 Apr; 12(1):6120. PubMed ID: 35449173
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish Larvae Position Tracker (Z-LaP Tracker): a high-throughput deep-learning behavioral approach for the identification of calcineurin pathway-modulating drugs using zebrafish larvae.
Gore SV; Kakodkar R; Del Rosario Hernández T; Edmister ST; Creton R
Sci Rep; 2023 Feb; 13(1):3174. PubMed ID: 36823315
[TBL] [Abstract][Full Text] [Related]
5. A zebrafish model for calcineurin-dependent brain function.
Tucker Edmister S; Ibrahim R; Kakodkar R; Kreiling JA; Creton R
Behav Brain Res; 2022 Jan; 416():113544. PubMed ID: 34425181
[TBL] [Abstract][Full Text] [Related]
6. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
7. Modulation of calcineurin signaling during development.
Tucker Edmister S; Creton R
Dev Neurobiol; 2022 Sep; 82(6):505-516. PubMed ID: 35785416
[TBL] [Abstract][Full Text] [Related]
8. Hybrid neural network approaches to predict drug-target binding affinity for drug repurposing: screening for potential leads for Alzheimer's disease.
Wu X; Li Z; Chen G; Yin Y; Chen CY
Front Mol Biosci; 2023; 10():1227371. PubMed ID: 37441162
[TBL] [Abstract][Full Text] [Related]
9. Computational Drug Repurposing for Alzheimer's Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies.
Xu Y; Kong J; Hu P
Front Pharmacol; 2021; 12():617537. PubMed ID: 34276354
[No Abstract] [Full Text] [Related]
10. The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer's Disease.
Shenoy A; Banerjee M; Upadhya A; Bagwe-Parab S; Kaur G
Front Behav Neurosci; 2022; 16():861155. PubMed ID: 35769627
[TBL] [Abstract][Full Text] [Related]
11. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
[TBL] [Abstract][Full Text] [Related]
12. Drug repurposing for Alzheimer's disease from 2012-2022-a 10-year literature review.
Grabowska ME; Huang A; Wen Z; Li B; Wei WQ
Front Pharmacol; 2023; 14():1257700. PubMed ID: 37745051
[No Abstract] [Full Text] [Related]
13. Reappraisal of FDA approved drugs against Alzheimer's disease based on differential gene expression and protein interaction network analysis: an in silico approach.
G N S HS; Ganesan Rajalekshmi S; Murahari M; Burri RR
J Biomol Struct Dyn; 2020 Aug; 38(13):3972-3989. PubMed ID: 31543038
[TBL] [Abstract][Full Text] [Related]
14. Comparative behavioral toxicology with two common larval fish models: Exploring relationships among modes of action and locomotor responses.
Steele WB; Kristofco LA; Corrales J; Saari GN; Haddad SP; Gallagher EP; Kavanagh TJ; Kostal J; Zimmerman JB; Voutchkova-Kostal A; Anastas P; Brooks BW
Sci Total Environ; 2018 Nov; 640-641():1587-1600. PubMed ID: 30021323
[TBL] [Abstract][Full Text] [Related]
15. Larval zebrafish model for studying the effects of valproic acid on neurodevelopment: An approach towards modeling autism.
Dwivedi S; Medishetti R; Rani R; Sevilimedu A; Kulkarni P; Yogeeswari P
J Pharmacol Toxicol Methods; 2019; 95():56-65. PubMed ID: 30500431
[TBL] [Abstract][Full Text] [Related]
16. Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease.
Wu Q; Su S; Cai C; Xu L; Fan X; Ke H; Dai Z; Fang S; Zhuo Y; Wang Q; Pan H; Gu Y; Fang J
Comput Struct Biotechnol J; 2023; 21():1907-1920. PubMed ID: 36936813
[TBL] [Abstract][Full Text] [Related]
17. Network-based stage-specific drug repurposing for Alzheimer's disease.
Savva K; Zachariou M; Bourdakou MM; Dietis N; Spyrou GM
Comput Struct Biotechnol J; 2022; 20():1427-1438. PubMed ID: 35386099
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.
Vargas DM; De Bastiani MA; Zimmer ER; Klamt F
Alzheimers Res Ther; 2018 Jun; 10(1):59. PubMed ID: 29935546
[TBL] [Abstract][Full Text] [Related]
19. Zebrafish Larvae as a Behavioral Model in Neuropharmacology.
Basnet RM; Zizioli D; Taweedet S; Finazzi D; Memo M
Biomedicines; 2019 Mar; 7(1):. PubMed ID: 30917585
[TBL] [Abstract][Full Text] [Related]
20. Effects of embryonic cyclosporine exposures on brain development and behavior.
Clift DE; Thorn RJ; Passarelli EA; Kapoor M; LoPiccolo MK; Richendrfer HA; Colwill RM; Creton R
Behav Brain Res; 2015 Apr; 282():117-24. PubMed ID: 25591474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
